Sort
130,381 grants matching “hiv”
The impact of intravenous heroin use on immune activation in treated HIV
$857,236Grace A McComsey · Case Western Reserve University · R01 · FY2021 · DA
Trans-complementing papillioma virus for AIDS vaccine
$857,135Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2017 · AI
Complete genomic DNA sequence of the sooty mangabey MHC
$857,111Daniel E Geraghty · Fred Hutchinson Cancer Research Center · R24 · FY2012 · OD
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
$857,109Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2022 · AI
THE BOSTON HAPPENS ADOLESCENT MEDICINE TRIALS UNIT
$857,062Children'S Hospital Boston · U01 · FY2002 · HD
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV
$857,028Natalia Teleshova · Population Council · R01 · FY2023 · AI
Critical Factors Influencing Echinocandin Resistance in Candida glabrata
$857,021David S Perlin · Hackensack University Medical Center · R01 · FY2023 · AI
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
$856,952Rebecca Schnall · Columbia University Health Sciences · R01 · FY2018 · MH
Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level
$856,949Ya-Chi Ho · Yale University · R01 · FY2023 · AI
Nucleic Acid Footprinting and development of small molecule antagonists
$856,937Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Viral Testing
$856,840Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2021 · OD
Viral Testing
$856,840Carlos A Sariol · University Of Puerto Rico Med Sciences · U42 · FY2020 · OD
The impact of intravenous heroin use on immune activation in treated HIV
$856,800Grace A McComsey · Case Western Reserve University · R01 · FY2020 · DA
Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme
$856,769Diako Ebrahimi · Texas Biomedical Research Institute · R01 · FY2024 · AI
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT
$856,761University Of Wisconsin Madison · R01 · FY2004 · AI
Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities
$856,702Charles T Roberts · Oregon Health & Science University · R01 · FY2019 · DK
Kinetics, evolution, and effector function of Fc repertoires during vaccination with native-like Env trimers
$856,679D. Noah Sather · Seattle Children'S Hospital · R01 · FY2023 · AI
REDUCE THE IMPACT OF HIV IN SO SUDAN, UNDER PRES EMERG PLAN F/AIDS RELIEF
$856,651Karen Blyth · Intrahealth International, Inc. · U62 · FY2009 · PS
ADOLESCENT MEDICINE TRIALS UNIT
$856,517Donna Futterman · Albert Einstein College Of Medicine · U01 · FY2011 · HD
Mechanisms of Antibody Fc Mediated Protection
$856,265Georgia D Tomaras · Duke University · P01 · FY2023 · AI
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
$856,238Scott G Hansen · Oregon Health & Science University · R01 · FY2017 · AI
Stanford AIDS Clinical Trials Unit
$856,218Andrew Zolopa · Stanford University · U01 · FY2010 · AI
STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
$856,202Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2025 · AI
Project 1: Immunization strategies to elicit broadly neutralizing antibodies against HIV-1
$856,199Pamela J Bjorkman · California Institute Of Technology · P01 · FY2020 · AI
Omics Analyses of HIV and Substance Use Disorder
$856,189Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2021 · DA